Long-term survival of patients with renal transplantation in Fabry's disease

Contributions to Nephrology

Volumn 136, Issue , 2001, Pages 229-233

  Mignani, R ^a   Gerra, D ^b   Maidini, L ^a   Bignardi, L ^b   Casanova, S ^c   Cambi, V ^b   Cagnoli, L ^a  

^a Ospedale Civile Infermi   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FABRY DISEASE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MORTALITY; SURVIVOR;

ADULT; FABRY DISEASE; HUMANS; KIDNEY TRANSPLANTATION; MALE; SURVIVORS;

EID: 0035537930     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060191     Document Type: Article

References (18)

1. Bishop DF, Kornreich R, Desnick RJ: Structural organization of the α-galactosidase A gene: Further evidence for the absence of a 3′ untranslated region. Proc Natl Acad Sci USA 1988;85:3903-3907.
2. Knol IE, Ausems MGEM, Lindhout D, van Diggelen OP, Verwey H, Davies J, Ploss van Amstel JK, Poll-The BT: Different phenotypic expression in relatives with Fabry disease caused by a W226X mutation. Am J Med Genet 1999;82:436-439.
3. Tsakiris D, Simpson HKL, Jones EHP, Briggs JD, Elinder CG, Mendel S, Piccoli G, dos Santos JP, Tognoni G, Vanrenterghem Y, Valderrabano F: Rare diseases in renal replacement therapy in the ERA-EDTA Registry. Nephrol Dial Transplant 1996;11(suppl 7):4-20.
4. Desnick RJ, Bishop DF: Fabry disease: α-galactosidase deficiency; Schindler disease: α-N-acetylgalactosaminidase deficiency; in Scriver CR, Beaudet Al, Sly WS, Valle D (eds): The Molecular Basis of Inherited Disease. New York, McGraw-Hill, 1989, pp 1751-1796.
5. Van Loo A, Vanholder R, Madsen K, Praet M, Kint J, De Paepe A, Messiaen L, Lameire N, Hasholt L, Sorensen SA, Ringoir S: Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure. Am J Nephrol 1996;16:352-357.
6. Praet M, Quatacker J, Van Loo A, Vanholder R, Lameire N, Ringoir S: Non-invasive diagnosis of Fabry's disease by electron microscopic evaluation of urinary sediment. Nephrol Dial Transplant 1995;10:902-903.
7. Ojo A, Meier-Kriesche HU, Friedman G, Hanson J, Cibrik D, Leichtman A, Kaplan B: Excellent outcome of renal transplantation in patients with Fabry's disease. Transplantation 2000;69:2337-2339.
8. Gantenbein H, Bruder E, Burger HR, Briner J, Binswanger U: Recurrence of Fabry's disease in a renal allograft 14 years after transplantation. Nephrol Dial Transplant 1995;10:287-289.
9. Friedlaender MM, Kopolovic J, Rubinger D, Silver J, Drukker A, Ben-Gershon Z, Durst AL, Popovtzer MM: Renal biopsy in Fabry's disease eight years after successful renal transplantation. Clin Nephrol 1987;27:206-211.
10. Mosnier JF, Degott C, Bedrossian J, Molas G, Degos F, Pruna A, Potet F: Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation. Transplantation 1991;51:759-762.
11. Faraggiana T, Churg J, Grishman E, Stauss L, Prado A, Bishop DF, Schuchman E, Desnick RJ. Light and electron microscopic histochemistry of Fabry's disease. Am J Pathol 1981;103:247-262.
12. Peces R: Is there true recurrence of Fabry's disease in the transplanted kidney? Nephrol Dial Transplant 1996;11(suppl 3):561.
13. ErtenY, Ozdemir FN, Demirhan B, Karakayali H, Demirag A, Akkoç H: A case of Fabry's disease with normal kidney function at 10 years after successful renal transplantation. Transplant Proc 1998;30:842-843.
14. Desnick RJ, Simmons RL, Allen KKY, Woods JE, Anderson CF, Najarian JS, Krivit W: Correction of enzymatic deficiencies by renal transplantation: Fabry's disease. Surgery 1972;72:203-211.
15. Philippart M, Franklin SS, Gordon A: Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation. Ann Intern Med 1972;77:195-200.
16. Peces R, Aguado S, Fernandez F: Renal transplantation in Fabry's disease. Nephron 1989;51:294-295.
17. Wuthrich RP, Weinreich T, Binswanger U, Gloor HJ, Candinas D, Hailemariam S: Should living related kidney transplantation be considered for patients with renal failure due to Fabry's disease? Nephrol Dial Transplant 1998;13:2934-2936.
18. Schiffmann R, Murray GJ, Treco D, Daniel P, Sellos-Moura M, Myers M, Quirk JM, Zirzow GC, Borowski M, Loveday K, Anderson T, Gillespie F, Oliver KL, Jeffries NO, Doo E, Liang TJ, Kreps C, Gunter K, Frei K, Crutchfield K, Seiden RF, Brady RO: Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci USA 2000;97:365-370.